Ueno M - Search Results

1

Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction.

Okumura N, Sakamoto Y, Fujii K, Kitano J, Nakano S, Tsujimoto Y, Nakamura S, Ueno M, Hagiya M, Hamuro J, Matsuyama A, Suzuki S, Shiina T, Kinoshita S, Koizumi N. Okumura N, et al. Among authors: ueno m. Sci Rep. 2016 May 18;6:26113. doi: 10.1038/srep26113. Sci Rep. 2016. PMID: 27189516 Free PMC article.

2

Neural conversion of ES cells by an inductive activity on human amniotic membrane matrix.

Ueno M, Matsumura M, Watanabe K, Nakamura T, Osakada F, Takahashi M, Kawasaki H, Kinoshita S, Sasai Y. Ueno M, et al. Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9554-9. doi: 10.1073/pnas.0600104103. Epub 2006 Jun 9. Proc Natl Acad Sci U S A. 2006. PMID: 16766664 Free PMC article.

3

Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor.

Okumura N, Ueno M, Koizumi N, Sakamoto Y, Hirata K, Hamuro J, Kinoshita S. Okumura N, et al. Among authors: ueno m. Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3680-7. doi: 10.1167/iovs.08-2634. Epub 2009 Apr 22. Invest Ophthalmol Vis Sci. 2009. PMID: 19387080

4

Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops.

Okumura N, Koizumi N, Ueno M, Sakamoto Y, Takahashi H, Hirata K, Torii R, Hamuro J, Kinoshita S. Okumura N, et al. Among authors: ueno m. Br J Ophthalmol. 2011 Jul;95(7):1006-9. doi: 10.1136/bjo.2010.194571. Epub 2011 Mar 11. Br J Ophthalmol. 2011. PMID: 21398412

5

The new therapeutic concept of using a rho kinase inhibitor for the treatment of corneal endothelial dysfunction.

Okumura N, Koizumi N, Ueno M, Sakamoto Y, Takahashi H, Hamuro J, Kinoshita S. Okumura N, et al. Among authors: ueno m. Cornea. 2011 Oct;30 Suppl 1:S54-9. doi: 10.1097/ICO.0b013e3182281ee1. Cornea. 2011. PMID: 21912232

6

Common variants in CDKN2B-AS1 associated with optic-nerve vulnerability of glaucoma identified by genome-wide association studies in Japanese.

Nakano M, Ikeda Y, Tokuda Y, Fuwa M, Omi N, Ueno M, Imai K, Adachi H, Kageyama M, Mori K, Kinoshita S, Tashiro K. Nakano M, et al. Among authors: ueno m. PLoS One. 2012;7(3):e33389. doi: 10.1371/journal.pone.0033389. Epub 2012 Mar 12. PLoS One. 2012. PMID: 22428042 Free PMC article.

7

ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue.

Okumura N, Koizumi N, Ueno M, Sakamoto Y, Takahashi H, Tsuchiya H, Hamuro J, Kinoshita S. Okumura N, et al. Among authors: ueno m. Am J Pathol. 2012 Jul;181(1):268-77. doi: 10.1016/j.ajpath.2012.03.033. Epub 2012 Jun 14. Am J Pathol. 2012. PMID: 22704232 Free article.

8

A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma.

Yamamoto M, Quantock AJ, Young RD, Okumura N, Ueno M, Sakamoto Y, Kinoshita S, Koizumi N. Yamamoto M, et al. Among authors: ueno m. Mol Vis. 2012;18:1727-39. Epub 2012 Jun 27. Mol Vis. 2012. PMID: 22815626 Free PMC article.

9

The ROCK inhibitor eye drop accelerates corneal endothelium wound healing.

Okumura N, Koizumi N, Kay EP, Ueno M, Sakamoto Y, Nakamura S, Hamuro J, Kinoshita S. Okumura N, et al. Among authors: ueno m. Invest Ophthalmol Vis Sci. 2013 Apr 3;54(4):2493-502. doi: 10.1167/iovs.12-11320. Invest Ophthalmol Vis Sci. 2013. PMID: 23462749

10

Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs corneal dystrophy.

Koizumi N, Okumura N, Ueno M, Nakagawa H, Hamuro J, Kinoshita S. Koizumi N, et al. Among authors: ueno m. Cornea. 2013 Aug;32(8):1167-70. doi: 10.1097/ICO.0b013e318285475d. Cornea. 2013. PMID: 23715376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,980 results

Search Page

Filters